Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Total Non-Current Liabilities (2022 - 2025)

NewGenIvf (NIVF) has disclosed Total Non-Current Liabilities for 4 consecutive years, with $4.4 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 86.81% to $4.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2025, up 86.81% year-over-year, with the annual reading at $4.4 million for FY2025, 86.81% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $4.4 million at NewGenIvf, up from $2.3 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $4.4 million in Q4 2025, with the low at $118979.0 in Q4 2023.
  • Average Total Non-Current Liabilities over 4 years is $1.8 million, with a median of $1.3 million recorded in 2022.
  • The sharpest move saw Total Non-Current Liabilities plummeted 52.15% in 2023, then soared 1866.02% in 2024.
  • Over 4 years, Total Non-Current Liabilities stood at $248633.0 in 2022, then tumbled by 52.15% to $118979.0 in 2023, then skyrocketed by 1866.02% to $2.3 million in 2024, then soared by 86.81% to $4.4 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $4.4 million, $2.3 million, and $118979.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.